Janiczek Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $41.7K | Buy |
1,082
+177
| +20% | +$6.83K | 0.01% | 434 |
|
|
2024
Q1 | $38.9K | Hold |
905
| – | – | 0.01% | 448 |
|
|
2023
Q4 | $33.6K | Sell |
905
-30
| -3% | -$1.11K | 0.01% | 464 |
|
|
2023
Q3 | $34.1K | Sell |
935
-1,061
| -53% | -$38.7K | 0.01% | 427 |
|
|
2023
Q2 | $71.3K | Buy |
1,996
+117
| +6% | +$4.18K | 0.02% | 265 |
|
|
2023
Q1 | $71K | Buy |
1,879
+964
| +105% | +$36.4K | 0.02% | 261 |
|
|
2022
Q4 | $32.2K | Buy |
915
+304
| +50% | +$10.7K | 0.01% | 378 |
|
|
2022
Q3 | $18K | Buy |
611
+321
| +111% | +$9.46K | 0.01% | 465 |
|
|
2022
Q2 | $15K | Sell |
290
-479
| -62% | -$24.8K | ﹤0.01% | 507 |
|
|
2022
Q1 | $42K | Buy |
769
+361
| +88% | +$19.7K | 0.01% | 328 |
|
|
2021
Q4 | $22K | Sell |
408
-25
| -6% | -$1.35K | 0.01% | 459 |
|
|
2021
Q3 | $21K | Buy |
433
+6
| +1% | +$291 | 0.01% | 448 |
|
|
2021
Q2 | $21K | Buy |
427
+203
| +91% | +$9.98K | 0.01% | 414 |
|
|
2021
Q1 | $10K | Buy |
224
+150
| +203% | +$6.7K | ﹤0.01% | 529 |
|
|
2020
Q4 | $3K | Hold |
74
| – | – | ﹤0.01% | 649 |
|
|
2020
Q3 | $4K | Hold |
74
| – | – | ﹤0.01% | 379 |
|
|
2020
Q2 | $4K | Buy |
+74
| New | +$4K | ﹤0.01% | 201 |
|